Gonadoblastoma differential diagnosis: Difference between revisions
No edit summary |
|||
| Line 12: | Line 12: | ||
*17-Hydroxylase (17-OH) deficiency syndrome | *17-Hydroxylase (17-OH) deficiency syndrome | ||
*[[Turner syndrome|Turner Syndrome]] | *[[Turner syndrome|Turner Syndrome]] | ||
* | *[[Swyer Syndrome]] | ||
*5-Alpha-Reductase Deficiency | *5-Alpha-Reductase Deficiency | ||
*[[Congenital adrenal hyperplasia (CAH)|Congenital adrenal hyperplasia]] | *[[Congenital adrenal hyperplasia (CAH)|Congenital adrenal hyperplasia]] | ||
Revision as of 18:54, 12 February 2019
For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
Gonadoblastoma must be differentiated from other diseases that cause virilization, and primary amenorrhea and also must be differentiated pathologically from dysgerminoma, Sex-cord stromal tumors, and Sertoli-cell nodules.
Differentiating Gonadoblastoma from other Diseases
Gonadoblastoma must be differentiated from other diseases that cause disorders of sex development, ambiguous genitalia, virilization, and primary amenorrhea such as:
- 17-Hydroxylase (17-OH) deficiency syndrome
- Turner Syndrome
- Swyer Syndrome
- 5-Alpha-Reductase Deficiency
- Congenital adrenal hyperplasia
- Hypospadias
- Undescended testis
Gonadoblastoma must be differentiated pathologically from:[1][2]
- dysgerminoma
- Sex-cord stromal tumors
- Sertoli-cell nodules
Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
| Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Physical examination | ||||||||||||||
| Lab Findings | Imaging | Histopathology | |||||||||||||
| Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | ||||
| Differential Diagnosis 1 | |||||||||||||||
| Differential Diagnosis 2 | |||||||||||||||
| Differential Diagnosis 3 | |||||||||||||||
| Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings |
| Differential Diagnosis 4 | |||||||||||||||
| Differential Diagnosis 5 | |||||||||||||||
| Differential Diagnosis 6 | |||||||||||||||
References
- ↑ Sperling, M (2014). Pediatric endocrinology. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1-4557-4858-7.
- ↑ Eble, John (2004). Pathology and genetics of tumours of the urinary system and male genital organs. Lyon Oxford: IARC Press Oxford University Press (distributor. ISBN 9283224159.